Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: Sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase

Journal of the Neurological Sciences

Volumn 164, Issue 1, 1999, Pages 13-23

  Martínez, Isabel ^a   Puerta, Carmen ^a   Redondo, Clara ^b   García Merino, Antonio ^a  

^a Dept Exp Biochem Clin Puerta H   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Adhesion molecules; Central nervous system; Cytokines; Experimental allergic encephalomyelitis; Nitric oxide; Phosphodiesterase IV

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; LYMPHOTOXIN; MESSENGER RNA; MYELIN BASIC PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GUINEA PIG; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; T LYMPHOCYTE;

ANIMALS; CELL ADHESION MOLECULES; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION; GUINEA PIGS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHODIESTERASE INHIBITORS; PYRROLIDINONES; RATS; RATS, INBRED LEW; ROLIPRAM; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0345517245     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00050-7     Document Type: Article

References (56)

1. Swanborg R.H. Experimental allergic encephalomyelitis. Methods Enzymol. 162:1988;413-421.
2. Khoruts A., Miller S.D., Jenkins M.K. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J Immunol. 155:1995;5011-5017.
3. Sobel R.A., Blanchette B.W., Bhan A.K., Colvin R.B. The immunopathology of experimental allergic encephalomyelitis: I. Quantitative analysis of inflammatory cells in situ. J Immunol. 132:1984;2394-2401.
4. Polman C.H., Dijkstra C.D., Sminia T., Koetsier J.C. Immunohistological analysis of macrophages in the central nervous system of Lewis rats with experimental allergic encephalomyelitis. J Neuroimmunol. 11:1986;215-222.
5. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunological Reviews. 144:1995;245-268.
6. Van der Veen R.C., Stohlman S.A. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J Neuroimmunol. 48:1993;213-220.
7. Koproski H., Zheng Y.M., Heber-Katz E., Fraser N., Rorke L., Fu Z.F., Hanlon C., Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic disease. Proc Natl Acad Sci USA. 90:1993;3024-3027.
8. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J Neuroimmunol. 73:1997;107-116.
9. Bö L., Dawson T.M., Wesselingh S., Mörk S., Choi S., Kons P.A., Hanley D., Trapp B. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol. 36:1994;778-786.
10. Ding M., Zhang M., Wong J.L., Rogers N.E., Ignarro L.J., Voskuhl R.R. Cutting edge: antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J Immunol. 160:1998;2560-2564.
11. Lee S.C., Dickson D.W., Liu W., Brosnan C.F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-γ J Neuroimmunol. 46:1993;19-24.
12. Misko T.P., Trotter J.L., Cross A.H. Mediation of inflammation by encephalitogenic cells: interferon-γ induction of nitric oxide synthase and cyclooxygenase 2. J Neuroimmunol. 61:1995;195-204.
13. Hewett S.J., Misko T.P., Keeling R.M., Behrens M.M., Choi D.W., Cross A.H. Murine encephalitogenic lymphoid cells induce nitric oxide synthase in primary astrocytes. J Neuroimmunol. 64:1996;201-208.
14. Zielasek J., Jung S., Gold R., Liew F.Y., Toyka K.V., Hartung H.P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J Neuroimmunol. 58:1995;81-88.
15. Ruuls S., Van Der Linden S., Sontrop K., Huitinga Y., Dijkstra C. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin Exp Immunol. 103:1996;467-474.
16. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest. 93:1994;2384-2390.
17. Novak T.J., Rothenberg E.V. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cell. Proc Natl Acad Sci USA. 87:1990;9353-9357.
18. Kammer G.M. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today. 9:1988;222-229.
19. Valitutti S., Dessing M., Lanzavecchia A. Role of cAMP in regulating cytotoxic T lymphocyte adhesion and motility. Eur J Immunol. 23:1993;790-795.
20. Wachtel H., Schneider H.H. Rolipram, a novel antidepressant drug, reverse the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptor. Neuropharmacology. 25:1986;1119-1126.
21. Mac Laughlin M.M., Cieslinski L.B., Burman M., Torphy T.J., Livi G.P. A low-Km Rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. J Biol Chem. 268:1993;6470-6476.
22. Livi G.P., Kmetz P., Mac Hale M.M., Cieslinski L.B., Sathe G.M., Taylor D.P., Davis L.R., Torphy T.J., Balcarek J.M. Cloning and expression of cDNA for a human low-KM Rolipram-sensitive cyclic AMP phosphodiesterase. Mol Cell Biol. 10:1990;2678-2686.
23. Ichimura M., Kase H. A new cyclic nucleotide phosphodiesterase isozyme expressed in the T-lymphocyte cell lines. Biochem Biophys Res Commun. 193:1993;985-990.
24. Sommer N., Löschmann P.A., Northoff G.H., Weller M., Steinbrecher A., Steinbach J.P., Lichtenfels R., Meyermann R., Riethmüller Fontana A., Dichgans J., Martin R. The antidepressant Rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med. 1:1995;243-248.
25. Genain C.P., Roberts T., Davis R.L., Nguyen M., Uccelli A., Faulds D., Li Y., Hedgpeth J., Hauser S.L. Prevention of autoimmune demyelination in nonhuman primates by a cAMP-specific phosphodiesterase inhibitor. Proc Natl Acad Sci USA. 92:1995;3601-3605.
26. Jung S., Zielasek J., Kollner G., Donhauser T., Toyka K., Hartung H. Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats. J Neuroimmunol. 68:1996;1-11.
27. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messenger RNA levels of IL-1β, IL-6 and LIF in the rat brain. Biochem Biophys Res Commun. 176:1991;593-598.
28. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Short Protocols in Molecular Biology. 2nd edition :1992;2-24 Harvard Medical School.
29. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol. 149:1992;2496-2505.
30. Bauer J., Berkenbosch F., Van Dam A., Dijkstra C.D. Demonstration of interleukin-1β in Lewis rats during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J Neuroimmunol. 48:1993;13-22.
31. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med. 176:1992;1355-1364.
32. Issazadeh S., Ljungdahl A., Höjeberg B., Mustafa M., Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β J Neuroimmunol. 61:1995;205-212.
33. Issazadeh S., Mustafa M., Ljungdahl A., Höjeberg B., Dagerlind A., Elde R., Olsson T. Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res. 40:1995;579-590.
34. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakoda S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J Neuroimmunol. 62:1995;103-112.
35. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol. 24:1994;1434-1440.
36. Sommer N., Martin R., McFarland H.F., Quigley L., Cannella B., Raine C.S., Scott D.E., Löschmann P.A., Racke M.K. Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease. J Neuroimmunol. 79:1997;54-61.
37. Körner H., Lemckert F.A., Chaudhri G., Etteldorf S., Sedgwick J.D. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur J Immunol. 27:1997;1973-1981.
38. Rieckmann P., Weber F., Günther A., Martin S., Bitsch A., Broocks A., Kitze B., Weber T., Börner T., Poser S. Pentoxifilline a phosphodiesterase inhibitor induces immune deviation in patients with multiple sclerosis. J Neuroimmunol. 64:1996;193-200.
39. Dustin M.L., Springer T.A. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature. 341:1989;619-624.
40. Rovere P., Inverardi L., Bender J.R., Pardi R. Feedback modulation of ligand-engaged aL/b2 leukocyte integrin (LFA-1) by cyclic AMP-dependent protein kinase. J Immunol. 156:1996;2273-2279.
41. Oppenheimer-Marks N., Kavanaugh A.F., Lipsky P.E. Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E2. J Immunol. 152:1994;5703-5713.
42. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S.J., Garside P., Padron J., Phillips R.S. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol. 24:1994;980-984.
43. Florquin S., Amraoui Z., Dubois C., Decuyper J., Goldman M. The protective role of endogenously synthesized nitric oxide in staphylococcal enteroxin B-induced shock in mice. J Exp Med. 180:1994;1153-1158.
44. Kunz D., Mühl H., Walker G., Pfeilschifter J. Two distinct signalling pathways trigger the expression of inducible nitric oxide synthase in rat mesangial cells. Proc Natl Acad Sci USA. 91:1994;5387-5391.
45. Alonso A., Carvalho J., Alonso-Torres S.R., Núñez L., Boska L., Sánchez Crespo M. Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues. Evidence in favor of a common signalling mechanism. J Immunol. 154:1995;6475-6483.
46. Eberhardt W., Kunz D., Hummel R., Pfeilschifter J. Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem Biophys Res Comm. 233:1996;752-756.
47. Bayón Y., Alonso A., Sánchez Crespo M. Immunoglobulin-E/Dinitrophenyl complexes induce nitric oxide synthesis in rat peritoneal macrophages by a mechanism involving CD23 and NF-kB activation. Biochem Biophys Res Com. 242:1998;570-574.
48. Gold D.P., Schroder K., Powell H.C., Kelly C.J. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur J Immunol. 27:1997;2863-2869.
49. Cross A.H., Keeling R.M., Goorha S., San M., Rodi C., Wyatt P.S., Manning P.T., Misko T.P. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J Neuroimmunol. 71:1996;145-153.
50. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol. 151:1993;2132-2141.
51. Lin R.F., Lin T.S., Tilton R.G., Cross A.H. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic study. J Exp Med. 178:1993;643-648.
52. Sahrbacher U.C., Lechner F., Eugster H.P., Frei K., Lassmann H., Fontana A. Mice with inactivation of the inducible nitric oxide synthase are susceptible to experimental autoimmune encephalomyelitis. Eur J Immunol. 28:1998;1332-1338.
53. Fenyk-Melody J.E., Garrison A.E., Brunnert S.R., Weidner J.R., Shen F., Shelton B.A., Mudgett J.S. Experimental autoimmune encephalomyelitis is excaerbated in mice lacking the NOS2 gene. J Immunol. 160:1998;2940-2946.
54. Crowden W.B., Cullen F.A., Staykova M.A., Willenborg D.O. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J Neuroimmunol. 88:1998;1-8.
55. Kambayashi T., Jacob C.O., Zhou D., Mazurek N., Fong M., Strassmann G. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J Immunol. 155:1995;4909-4916.
56. Haskó G., Zsabó C., Németh Z.H., Salzman A.L., Vizi E.S. Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent. Eur J Immunol. 28:1998;468-472.